Supplementary Figure 2 from Low-Dose Metronomic Oral Dosing of a Prodrug of Gemcitabine (LY2334737) Causes Antitumor Effects in the Absence of Inhibition of Systemic Vasculogenesis

Authors :: Robert S. Kerbel
F. Stuart Foster
Anne H. Dantzig
Mark Uhlik
Julie Stewart
Christina Hackl
Shan Man
Ping Xu
Carolyn Cesta
Melissa Yin
John Sun
Kae Hashimoto
Yuval Shaked
Giulio Francia
Publication Year :: 2023
Publisher :: American Association for Cancer Research (AACR), 2023.
Abstract: PDF file - 6.5MB

Tools